27
BROAD SPECTRUM ANTIBIOTICS TETRACYCLINES CHLORAMPHENICOL

7. broad spectrum ab

Embed Size (px)

Citation preview

Page 1: 7. broad spectrum ab

BROAD SPECTRUM ANTIBIOTICS

TETRACYCLINES

CHLORAMPHENICOL

Page 2: 7. broad spectrum ab
Page 3: 7. broad spectrum ab

Tetra cyclines have four cyclic ring Produced by genus Streptomyces

Page 4: 7. broad spectrum ab

Tetracycline divided into:

a) Naturally occurring:Tetracycline ChlortetracyclineOxytetracycline Demeclocycline

b) Semisynthetic occurring:Doxycycline MinocyclineMeclocycline LymecyclineMethacycline Rolitetracycline

Page 5: 7. broad spectrum ab

CLASSIFICATION OF TETRACYCLINES

GROUP I : Chlortetracycline(6-10hr) Tetracycline

Oxytetracycline

GROUP II : Demeclocycline(12-13hr) Methacycline

GROUP III : Doxycycline(18-20hrs) Minocycline

Page 6: 7. broad spectrum ab

Mechanism of Action BACTERIOSTATIC

1. Drug enter by : Active Transport (+Ve)

Porin channels (-Ve)

Enter into periplasmic place Protein Carrier system

Inner cytoplasmic membrane

Binds to 30s ribosome

Inhibits attach of aminoacyl t RNA to “A”site

Inhibition of protein synthesis

Page 7: 7. broad spectrum ab

ANTIMICROBIAL SPECTRUM

G +ve Bacilli :

* Clostridia * Corynebacteria

* B. Anthracis * P. acnes

G –ve Bacilli :* V. Cholerae * Brucella* H. ducryi * H. pylori* Y. pestis * Y. enterocolitica

G +ve Cocci :

* Streptococci * Staphylococci

G –ve Cocci :* N. gonococci * N. meningococci

Page 8: 7. broad spectrum ab

ANTIMICROBIAL SPECTRUM cont…

Rickettiae

Chlamydiae

Mycoplasma

Actinomyces

Spirochetes

Entamoeba

Plasmodia

Page 9: 7. broad spectrum ab

RESISTANCE

1. Active transport Mechanism

2. Pumping Out of Drug √

3. Protective Protein – Microorganism

4. Complete Cross Resistance

5. Partial Cross Resistance

Page 10: 7. broad spectrum ab
Page 11: 7. broad spectrum ab

PHARMACOKINETICS

ABSORPTION :* Group I & II – Incomplete; Empty Stomach* Group III – Complete* Chelating Property

DISTRIBUTION :* Liver, Spleen, Bones & Teeth, cross Placenta

EXCRETION :* Group I & II – Kidney (70-75%)

* Group III – Bile & Faeces - Enterohepatic Circulation (Doxy)

* All Tetracycline – Milk* Mino- saliva and tears

Page 12: 7. broad spectrum ab

ADVERSE EFFECTS

1. LOCAL IRRITANCY (IM)

2. HEPATOTOXICITY (preg., Inc. blood urea levels)

3. NEPHROTOXICITY (I &II)

4. TOXICITY TO TEETH & BONES

5. PHOTOSENSITIVITY –III (Sun burn, Doxy)

Page 13: 7. broad spectrum ab

ADVERSE EFFECTS cont…

6. VESTIBULAR TOXICITY –III (acc.lipid cells of inner ear)

7. SUPERINFECTION

8. HYPERSENSITIVITY

9. Pseudotumor cerebri (Adults) & Bulging

fontanelles

10. DIABETES INSIPIDUS LIKE CONDITION (Mino, Anti ADH action)

Page 14: 7. broad spectrum ab

THERAPEUTIC USES

FIRST CHOICE DRUG :

1. Venereal Diseases

2. Chlamydieal Infections

3. Brucellosis (with streptomycin)

4. Atypical Pneumonia

5. Plague prophylaxis

6. Cholera

7. Rickettseial Infections (Doxy)

8. Relapsing Fever (Doxy)

Page 15: 7. broad spectrum ab

THERAPEUTIC USES

SEACOND CHOICE DRUG :

To Penicillin

* Tetanus * Anthrax *Actinomycosis

To Cotrimoxazole : E. coli infection

To Streptomycin : Tulaeremia

To Ciprofloxacin : Gonorrhoea &

Syphilis

Azithromycin : Chlamydial Infection

Page 16: 7. broad spectrum ab

THERAPEUTIC USEScont…

MISCELLANEOUS CONDITION :1. Amoebiasis2. Malaria3. Acne4. COPD

MINOCYCLINE:

1. Meningococal meningitis

2. Community Acquired Pneumonia

3. Chronic Intestinal Amoebiasis

Page 17: 7. broad spectrum ab

Glycylcyclins

Synthetic deriv. of Minocyclines Potent than Mino Effect Gm +ve, -Ve, aerobes,

Anaerobes, resistant tetracyclines Same mech, resistance

Page 18: 7. broad spectrum ab

CHLORAMPHENICOL

Page 19: 7. broad spectrum ab

CHLORAMPHENICOL

MECHANISM OF ACTION :

Inhibits Protein Synthesis : 50 s Ribosomes (Inhibit

formation of peptide bond)

High Doses : Inhibits Mammalian

Mitochondrial Protein Synthesis

Page 20: 7. broad spectrum ab

ANTIMICROBIAL SPECTRUM

BACTERIOSTATIC

BACTERIOCIDAL – H. influenzae

BROAD SPECTRUM as TETRACYCLINES

Additional Spectrum:

HIGHLY ACTIVE– Salmonella

MORE ACTIVE - H. influenzae, B. pertusis,

Klebsiella & Anaerobes

LESS ACTIVE – G+ve cocci, Spirochetes.

INACTIVE – Entamoeba & Plasmodia

Page 21: 7. broad spectrum ab

RESISTANCE

1. Transfer of R Factor

2. Formation of Acetyl Transferase

3. Decreased Permeability

4. Lowered Affinity of Bacterial

Ribosome

Page 22: 7. broad spectrum ab

PHARMACOKINETICS

Oral Absorption : Complete

Distribution : CSF, Bile, Synovial Memb

Milk, Placenta.

Metabolism : Conjugation in Liver

Excretion : Unchanged in Urine

Page 23: 7. broad spectrum ab

ADVERSE EFFECTS

Page 24: 7. broad spectrum ab

ADVERSE EFFECTS

1. Bone Marrow Toxicity Non Dose Related (3-4g/day for 1-2week)

Inhibition of mitochondrial enzymes Dose Related Aplastic Anaemia

Thrombocytopenia Agranulocytosis

2. Gray Baby Syndrome

3. Superinfection

4. Irritative Effects

Page 25: 7. broad spectrum ab

THERAPEUTIC USES

1. H. Influenza Meningitis

2. Anaerobic Infections

3. Enteric Fever

4. Intraocular Infection

5. As Second Choice Drug :

To Tetracycline : Cholera, Brucelosis, etc.

To Erythromycin: Whooping Cough

To Penicillin : Meningitis

To Cotrimoxazole : Shigella Dysentry

Page 26: 7. broad spectrum ab

IMP

All undergoes enterohepatic circulation CI in pregnancy and ,8 ye.old Outdated lead to Fanconi’s syndrome

( Renal tubular acidosis) Minocyclines cause dose dependent

vestibular toxicity Tetracycline's posses anti anabolic

effects

Page 27: 7. broad spectrum ab